Doctors at Queen Elizabeth Hospitals Kings Lynn Awarded Prestigious NHS England Fellowship
7 July 2015
Healthcare pioneers receive national support to roll out innovative technologies to patients, hospitals and GP practices throughout England.
Health Enterprise East (HEE) congratulates Drs Maryanne Mariyaselvam and Peter Young of Queen Elizabeth Hospitals Kings Lynn (QEHKL), on becoming fellows of the NHS Innovation Accelerator (NIA) programme. The scheme, announced on Monday by Sir Bruce Keogh NHS England’s Medical Director, sets out to get evidenced healthcare innovations adopted at scale and pace nationally, ultimately making them more widely available to patients. QEHKL is a HEE Member Trust; both Dr Mariyaselvam’s and Dr Young’s technologies were originally progressed with support of HEE who has assisted with the development of both projects to date.
Dr Mariyaselvam and Dr Young join a prestigious group of 17 healthcare pioneers from the UK and abroad identified to receive national support to roll out their technologies, processes and models of care to patients, hospitals and GP practices throughout England. Through the fellowship, each will receive mentorship from seasoned innovators such as Lord Ara Darzi, a bursary, and support to spread these new ways of working across the country.
Dr Mariyaselvam’s innovation, the Non-Injectable Arterial Connector (NIC), will improve the safety and care of all patients requiring an arterial line in operating theatres and intensive care.
Dr Young’s innovation, the PneuX Pneumonia Prevention System, is designed to stop ventilator-associated pneumonia (VAP), the leading cause of hospital-acquired mortality in intensive care units.
In a joint comment Drs Mariyaselvam and Young said, "Innovation should be at the heart of the NHS, as should mechanisms for spreading innovative solutions to patients quickly and effectively. We are delighted that both technologies have been selected for the NIA programme and with the support of NHS England, we look forward to seeing them scaled and implemented nationally across the NHS. As a Member Trust, QEHKL is thankful to HEE for its help in the development of the projects to date and in reaching this significant milestone."
“This is great news from one of our Members Trust and we pass on our sincerest congratulations to Maryanne and Peter on being awarded NIA fellowships,” commented Stuart Thomson, Commercialisation Director, HEE. “Having worked closely with the inventors, clinical team and QEH on these and other projects, we are delighted that both innovations will be receiving NHS England support for national roll out in order to deliver significant and wide reaching patient benefit.”
For more information on the NHS Innovation Accelerator click here
Dr Mariyaselvam and Dr Young join a prestigious group of 17 healthcare pioneers from the UK and abroad identified to receive national support to roll out their technologies, processes and models of care to patients, hospitals and GP practices throughout England. Through the fellowship, each will receive mentorship from seasoned innovators such as Lord Ara Darzi, a bursary, and support to spread these new ways of working across the country.
Dr Mariyaselvam’s innovation, the Non-Injectable Arterial Connector (NIC), will improve the safety and care of all patients requiring an arterial line in operating theatres and intensive care.
Dr Young’s innovation, the PneuX Pneumonia Prevention System, is designed to stop ventilator-associated pneumonia (VAP), the leading cause of hospital-acquired mortality in intensive care units.
In a joint comment Drs Mariyaselvam and Young said, "Innovation should be at the heart of the NHS, as should mechanisms for spreading innovative solutions to patients quickly and effectively. We are delighted that both technologies have been selected for the NIA programme and with the support of NHS England, we look forward to seeing them scaled and implemented nationally across the NHS. As a Member Trust, QEHKL is thankful to HEE for its help in the development of the projects to date and in reaching this significant milestone."
“This is great news from one of our Members Trust and we pass on our sincerest congratulations to Maryanne and Peter on being awarded NIA fellowships,” commented Stuart Thomson, Commercialisation Director, HEE. “Having worked closely with the inventors, clinical team and QEH on these and other projects, we are delighted that both innovations will be receiving NHS England support for national roll out in order to deliver significant and wide reaching patient benefit.”
For more information on the NHS Innovation Accelerator click here